Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.

HYPOTHESIS Histological grade of hepatocellular carcinoma (HCC) is an important prognostic factor affecting patient survival after orthotopic liver transplantation (OLT). DESIGN Retrospective analysis. SETTING University-based teaching hospital. PATIENTS Of 952 OLTs performed between June 1991 and January 1999, 56 OLT recipients had histologically proven HCC in the explant liver. Of those, 53 patients with complete clinicopathologic data were analyzed. A single pathologist blinded to the outcome of each patient reviewed all histological specimens. RESULTS Median follow-up was 709 days. Overall survival for patients with tumors sized 5 cm or less at 1, 3, and 5 years was 87%, 78%, and 71%, respectively (Kaplan-Meier). Univariate analysis revealed the size, number, and distribution of tumors; the presence of microscopic vascular invasion and lymph node metastasis; histological differentiation; and pTNM stage to be statistically significant factors affecting survival. Multivariate analysis revealed histological differentiation and pTNM stage to be the independent and statistically significant factors affecting survival (P =.002 and.03, respectively). When pTNM stage was excluded from multivariate analysis, histological differentiation and size remained the significant independent factors (P =.02 and.03, respectively). Three-year survival for patients with small (</=5 cm) tumor with well- to moderately differentiated and poorly differentiated HCC was 82% and 67%, respectively. Three-year survival for patients with large (>5 cm) tumor with well- to moderately differentiated and poorly differentiated HCC was 62.5% and 0%, respectively. CONCLUSIONS In our retrospective experience, histological differentiation had a statistically significant effect on the prognosis of HCC after OLT. However, before altering the current OLT selection criteria for patients with HCC, prospective studies are required to confirm the impact of histological grade on clinical outcome.

[1]  Toshihito Seki,et al.  Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma , 1994, Cancer.

[2]  A. Terano,et al.  Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. , 1993, AJR. American journal of roentgenology.

[3]  K. Olthoff,et al.  Adjuvant Chemotherapy Improves Survival After Liver Transplantation for Hepatocellular Carcinoma , 1995, Annals of surgery.

[4]  T. Starzl,et al.  Role of Liver Transplantation in Cancer Therapy , 1985, Annals of surgery.

[5]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[6]  Hong-Jin Kim,et al.  Surgical techniques and innovations in living related liver transplantation. , 1993, Annals of surgery.

[7]  D. V. van Thiel,et al.  Hepatic resection versus transplantation for hepatocellular carcinoma. , 1991, Annals of surgery.

[8]  H. Hasegawa,et al.  Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients , 1985, Cancer.

[9]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[10]  H. Bismuth,et al.  Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients , 1993, Annals of surgery.

[11]  E. Smith.  The hazards of fine-needle aspiration biopsy. , 1984, Ultrasound in medicine & biology.

[12]  D.,et al.  Regression Models and Life-Tables , 2022 .

[13]  R. Busuttil,et al.  Current Treatment Modalities for Hepatocellular Carcinoma , 1994, Annals of surgery.

[14]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[15]  L. Pączek,et al.  [Liver transplantation for hepatocellular carcinoma]. , 2003, Polskie Archiwum Medycyny Wewnetrznej.

[16]  H. Edmondson,et al.  Primary carcinoma of the liver. A study of 100 cases among 48,900 necropsies , 1954, Cancer.

[17]  L. Ellis,et al.  Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .

[18]  J. Bruix,et al.  Liver transplantation for small hepatocellular carcinoma: The tumor‐node‐metastasis classification does not have prognostic power , 1998, Hepatology.

[19]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[20]  K. Sugimachi,et al.  A valid new approach in treating solitary new lesions after resection of hepatocellular carcinoma , 1994, Journal of surgical oncology.

[21]  A. Venook.  Treatment of hepatocellular carcinoma: too many options? , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  L. Wong,et al.  Needle‐tract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[23]  C. Herfarth,et al.  Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. , 1998, Annals of surgery.

[24]  M. Rela,et al.  Domino hepatic transplantation using the liver from a patient with familial amyloid polyneuropathy. , 1998, Transplantation.

[25]  Y. Kondo.  Histologic features of hepatocellular carcinoma and allied disorders. , 1985, Pathology annual.

[26]  V. Mazzaferro,et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.

[27]  B. Portmann,et al.  Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome. , 1993, Journal of hepatology.

[28]  M. Kudo,et al.  Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA , 1999, Hepatology.

[29]  C. Chastang,et al.  Needle biopsy of hepatocellular carcinoma: Assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes , 1996, Cancer.

[30]  K. Tanikawa,et al.  The morphologic transition in hepatocellular carcinoma. A comparison of the individual histologic features disclosed by ultrasound‐guided fine‐needle biopsy with those of autopsy , 1992, Cancer.

[31]  H. Toyoda,et al.  Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma , 1997, Hepatology.

[32]  H. Miyake,et al.  Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  K. Reddy,et al.  'Domino' liver transplantation combined with multivisceral transplantation. , 1997, Archives of surgery.

[34]  G. Klintmalm.  Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. , 1998, Annals of surgery.

[35]  P. Brousse,et al.  Split liver transplantation , 2002, Steinkopff.

[36]  I. Penn.  Hepatic transplantation for primary and metastatic cancers of the liver. , 1991, Surgery.